Integration of Illness Management and Recovery Within ACT
Launched by UNIVERSITY OF WASHINGTON · Mar 8, 2017
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
Despite significant advances in pharmacological treatments, many individuals with severe mental illnesses (SMI) such as schizophrenia and bipolar disorder continue to experience significant impairments in crucial life areas such as employment, housing, social functioning, and daily living skills. In addition, many of these individuals have significant levels of psychotic, mood, or negative symptoms, and are prone to frequent relapses and re-hospitalizations. Psychosocial treatments are needed to improve illness management and functioning beyond the limited effects of medication. However, re...
Gender
ALL
Eligibility criteria
- • Eight ACT teams in two states were recruited, with four teams in each state.
- Selection criteria included:
- • 1. no prior IMR training; and
- • 2. good fidelity to ACT, defined as a score \> 3.5 (out of 5.0) on the Tool for Measurement of Assertive Community Treatment during state-sponsored fidelity assessments in 2012.
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Maria Monroe-DeVita, PhD
Principal Investigator
Co-PI, University of Washington, Seattle, WA
Gary Morse, PhD
Principal Investigator
Co-PI, Places for People, St. Louis, MO
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials